Tagrisso 80 mg (Osimertinib (Osimertinib Mesylate) TABLET) 80 MG

TAGRISSO 80 MG tablets contain osimertinib mesylate, a medication used in cancer treatment. This oral tablet is manufactured by AstraZeneca Canada Inc. and is designed for specific therapeutic uses.

Strength

80 MG

Pack Size

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TAGRISSO 80 MG tablets are primarily used in the treatment of certain types of cancer. Osimertinib mesylate, the active ingredient, is often prescribed for advanced non-small cell lung cancer with specific genetic markers. This medication is part of targeted therapy, aiming to address cancer cells with particular mutations. Patients should consult their healthcare provider to understand what is TAGRISSO used for in their specific case.

Side Effects

Common effects of TAGRISSO 80 MG tablets may include diarrhea, rash, and fatigue. Some individuals might experience nausea or changes in appetite. As with any medication, effects can vary, and not everyone will experience the same symptoms. It is important to monitor any side effects and discuss them with a healthcare professional.

Precautions & Warnings

TAGRISSO 80 MG tablets should be handled with care. Store the medication at room temperature, away from moisture and heat. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women or those planning to become pregnant should discuss the use of this medication with their doctor.

Avoid Interactions

TAGRISSO 80 MG tablets may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances may also interact with this medication, so it is advisable to consult a healthcare professional for personalized advice.

Frequently Asked Questions

TAGRISSO 80 MG tablets are used in the treatment of certain types of cancer, specifically non-small cell lung cancer with specific genetic markers.

Store TAGRISSO 80 MG tablets at room temperature, away from moisture and heat.

Common side effects may include diarrhea, rash, fatigue, nausea, and changes in appetite.

TAGRISSO may interact with certain medications, so it is important to consult your healthcare provider about all medications you are taking.

Pregnant women or those planning to become pregnant should discuss the use of TAGRISSO with their healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.